Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats.

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats.

Item

http://www.wikidata.org/entity/Q36787823

Q36787823

about

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats.

Item

http://www.wikidata.org/entity/Q36787823

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Use of micro-positron emission ...... actinomas of Fischer-344 rats.

@en

type

Item

label

Use of micro-positron emission ...... actinomas of Fischer-344 rats.

@en

prefLabel

Use of micro-positron emission ...... actinomas of Fischer-344 rats.

@en

P1476

Use of micro-positron emission ...... actinomas of Fischer-344 rats.

@en

P2093

Chuzhong Li

http://www.w3.org/2001/XMLSchema#string

Hua Gao

http://www.w3.org/2001/XMLSchema#string

Jiwei Bai

http://www.w3.org/2001/XMLSchema#string

Lei Cao

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Songbai Gui

http://www.w3.org/2001/XMLSchema#string

Yazhuo Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

The molecular pathogenesis of pituitary adenomas: an update

Evaluation of mild hypothermia therapy for neonatal hypoxic-ischaemic encephalopathy on brain energy metabolism using (18)F-fluorodeoxyglucose positron emission computed tomography.

Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.

Dopamine receptor agonists for treating prolactinomas.

Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.

Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary.

Efficacy of (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy.

Dopamine resistance of prolactinomas.

Positron emission tomography applied in the study of pituitary adenomas.

P304

2057-2068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S94057

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27103832

http://www.w3.org/2001/XMLSchema#string

P932

4827909

http://www.w3.org/2001/XMLSchema#string

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats.

about

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932